Last reviewed · How we verify
NCT06327919
Effects of Probiotic Supplementation With Weight Reducing Plan in Patients With Food Addiction and Weight Regain After Bariatric Surgery
NA trial testing Probiotic supplement in Weight Regain After Bariatric Surgery and Food Addiction in 50 participants. Completed in 23 September 2023.
25 May 2023
Quick facts
| Lead sponsor | National Nutrition and Food Technology Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 June 2022 |
| Primary completion | 25 May 2023 |
| Estimated completion | 23 September 2023 |
| Sites | 2 locations across Iran |
Drugs / interventions tested
- Probiotic supplement — full drug profile →
- Placebo supplement
Conditions studied
- Weight Regain After Bariatric Surgery and Food Addiction — all drugs for Weight Regain After Bariatric Surgery and Food Addiction →
Sponsor
National Nutrition and Food Technology Institute
Who can join
Adults 18 to 50, any sex, with Weight Regain After Bariatric Surgery and Food Addiction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To study the effects of probiotic supplementation with a weight loss program and cognitive behavioral therapy (CBT) on anthropometric measures, eating behavior, food addiction, and related hormone levels in patients with food addiction and weight regain after bariatric surgery, 50 patients who referred to obesity clinic with weight regain (regaining ≥10% nadir weight) after bariatric surgery (at least 18 months), and food addiction will be randomly allocated to receive a weight loss program and CBT plus either probiotic, or placebo for 12 weeks. At the first and the end of the intervention, anthropometric measurements, eating behavior, food addiction, leptin, serotonin, and oxytocin will be assessed and compared between groups.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06327919
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Probiotic supplement
Trials testing the same drug.
- NCT06052540 — Probiotic Supplementation in Children Affected by Upper Respiratory Infections · NA · unknown
- NCT05943925 — Dementias and Microbiota Composition: Is Possible to Revert the Dementia Symptoms Reverting the Microbiota Composition? · unknown
- NCT04798417 — Nutrition to Relieve IBS Constipation · NA · completed
- NCT03719794 — Probiotics for Vascular Inflammation in Metabolic Syndrome · NA · completed
- NCT03284905 — Probiotic Intervention for Acute Stress · NA · completed
Other National Nutrition and Food Technology Institute trials
Trials by the same sponsor.
- NCT06900946 — Evaluation of the Effects of Gluten Free Diet on Clinical Symptoms and Glycemic Index in Type 2 Diabetic Patients With N · NA · enrolling by invitation
- NCT06351696 — The Effects of Bromelain Supplement in Patients With Ulcerative Colitis · NA · recruiting
- NCT06353633 — The Effect of Exclusion Diet for Crohn's Disease Plus Enteral Nutrition on Children and Adolescents With Crohn's Disease · NA · not yet recruiting
- NCT06160830 — The Effects of Synbiotic on Cardiovascular and Bone Metabolism Markers in Transplanted Kidney Patients · NA · unknown
- NCT06096558 — The Effects of Melatonin on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06327919 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Nutrition and Food Technology Institute
- Last refreshed: 25 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06327919.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing